Feasibility study of NMR based serum metabolomic profiling to animal health monitoring: A case study on iron storage disease in captive sumatran rhinoceros (Dicerorhinus sumatrensis)

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Watanabe, Miki ^a   Roth, Terri L ^b   Bauer, Stuart J ^a   Lane, Adam ^a   Romick Rosendale, Lindsey E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Cincinnati Zoo and Botanical Garden   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ANIMAL HEALTH; ARTICLE; BLOOD SAMPLING; CARBON NUCLEAR MAGNETIC RESONANCE; CASE STUDY; CONTROLLED STUDY; DICERORHINUS SUMATRENSIS; DISEASE COURSE; DISEASE PREDISPOSITION; FEASIBILITY STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEALTH STATUS; HEMOCHROMATOSIS; HEMOSIDEROSIS; LIVER FAILURE; MALAYSIA; MAMMAL; METABOLITE; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OHIO; PROTON NUCLEAR MAGNETIC RESONANCE; WILD ANIMAL; ZOO ANIMAL; ANIMAL; BLOOD; CASE CONTROL STUDY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERISSODACTYLA; VETERINARY;

ANIMALS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEASIBILITY STUDIES; HEMOCHROMATOSIS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; PERISSODACTYLA;

EID: 84971663975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156318     Document Type: Article

References (48)

1. Dierenfeld ES, Atkinson S, Craig AM, Walker KC, Streich WJ, Clauss M. Mineral concentrations in serum/plasma and liver tissue of captive and free-ranging Rhinoceros species. Zoo Biology. 2005; 24(1):51-72. doi:10.1002/zoo.20043
2. Clauss M, Paglia DE. Iron storage disorders in captive wild mammals: the comparative evidence. Journal of zoo and wildlife medicine: official publication of the American Association of Zoo Veterinarians. 2012; 43(3 Suppl):S6-18. Epub 2012/11/20. doi:10.1638/2011-0152.1 PMID: 23156701.
3. Dierenfeld ES, Kilbourn A, Karesh W, Bosi E, Andau M, Alsisto S. Intake, utilization, and composition of browses consumed by the Sumatran rhinoceros (Dicerorhinus sumatrensis harissoni) in captivity in Sabah, Malaysia. Zoo Biology. 2006; 25(5):417-31. doi:10.1002/zoo.20107
4. Candra D, Radcliffe RW, Khan M, Tsu IH, Paglia DE. Browse Diversity And Iron Loading In Captive Sumatran Rhinoceroses (Dicerorhinus Sumatrensis): A Comparison Of Sanctuary And Zoological Populations. Journal of Zoo and Wildlife Medicine. 2012; 43(3s):S66-S73. doi:10.1638/2011-0127.1
5. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature genetics. 1996; 13(4):399-408. Epub 1996/08/01. doi:10.1038/ng0896-399 PMID: 8696333.
6. Beutler E, West C, Speir JA, Wilson IA, Worley M. The HFE Gene of Browsing and Grazing Rhinoceroses: A Possible Site of Adaptation to a Low-Iron Diet. Blood Cells, Molecules, and Diseases. 2001; 27(1):342-50. http://dx.doi.org/10.1006/bcmd.2001.0386. PMID: 11358396
7. Olias P, Mundhenk L, Bothe M, Ochs A, Gruber AD, Klopfleisch R. Iron overload syndrome in the black rhinoceros (Diceros bicornis): microscopical lesions and comparison with other rhinoceros species. Journal of comparative pathology. 2012; 147(4):542-9. Epub 2012/09/01. doi:10.1016/j.jcpa.2012.07.005 PMID: 22935088.
8. Roth TL. Development of a rhino ferritin specific assay for monitoring the progression of iron overload disorder in Sumatran rhinos (Dicerorhinus sumatrensis). Proceedings Workshop on Iron Overload Disorder in Browsing Rhinoceros, Progress Report, Pp14-15, Orlando, FL: 2016.
9. Paglia DE, Tsu IH. Review of laboratory and necropsy evidence for iron storage disease acquired by browser rhinoceroses. Journal of zoo and wildlife medicine: official publication of the American Association of Zoo Veterinarians. 2012; 43(3 Suppl):S92-104. Epub 2012/11/20. doi:10.1638/2011-0177.1 PMID: 23156711.
10. Bundy J, Davey M, Viant M. Environmental metabolomics: a critical review and future perspectives. Metabolomics. 2009; 5(1):3-21. doi:10.1007/s11306-008-0152-0
11. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nature reviewsDrug discovery. 2002; 1:153-61.
12. Nicholson JK, Wilson ID, Lindon JC. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics. 2011; 12(1):103-11. Epub 2010/12/23. doi:10.2217/pgs.10.157 PMID: 21174625.
13. Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009; 15:431-40.
14. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annual review of pharmacology and toxicology. 2008; 48:653-83. Epub 01/11. doi:10.1146/annurev.pharmtox.48.113006.094715 PMID: 18184107.
15. Southam AD, Easton JM, Stentiford GD, Ludwig C, Arvanitis TN, Viant MR. Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks. Journal of proteome research. 2008; 7:5277-85. doi:10.1021/pr800353t PMID: 19367724.
16. Schock TB, Newton S, Brenkert K, Leffler J, Bearden DW. An NMR-based metabolomic assessment of cultured cobia health in response to dietary manipulation. Food Chem. 2012; 133(1):90-101. PMID: WOS:000301826400013.
17. Schock TB, Duke J, Goodson A, Weldon D, Brunson J, Leffler JW, et al. Evaluation of Pacific White Shrimp (Litopenaeus vannamei) Health during a Superintensive Aquaculture Growout Using NMR-Based Metabolomics. PLoS One. 2013; 8(3). PMID: WOS:000317418500043.
18. Schock TB, Stancyk DA, Thibodeaux L, Burnett KG, Burnett LE, Boroujerdi AFB, et al. Metabolomic analysis of Atlantic blue crab, Callinectes sapidus, hemolymph following oxidative stress. Metabolomics. 2010; 6(2):250-62. PMID: WOS:000277298700009.
19. Jones OAH, Dondero F, Viarengo A, Griffin JL. Metabolic profiling of Mytilus galloprovincialis and its potential applications for pollution assessment. Marine Ecology Progress Series. 2008; 369:169-79. doi:10.3354/meps07654
20. Tuffnail W, Mills G, Cary P, Greenwood R. An environmental 1H NMR metabolomic study of the exposure of the marine mussel Mytilus edulis to atrazine, lindane, hypoxia and starvation. Metabolomics. 2009; 5:33-43. doi:10.1007/s11306-008-0143-1
21. Watanabe M, Meyer K, Jackson T, Schock T, Johnson WE, Bearden D. Application of NMR-based metabolomics for environmental assessment in the Great Lakes using zebra mussel (Dreissena polymorpha). Metabolomics. 2015; 11(5):1302-15. doi:10.1007/s11306-015-0789-4 PMID: 26366138
22. Dove ADM, Leisen J, Zhou M, Byrne JJ, Lim-Hing K, Webb HD, et al. Biomarkers of Whale Shark Health: A Metabolomic Approach. PLoS ONE. 2012; 7(11):e49379. doi:10.1371/journal.pone.0049379 PMID: 23166652
23. Niemuth JN, Stoskopf MK. Hepatic metabolomic investigation of the North American black bear (Ursus americanus) using 1H-NMR spectroscopy. Wildlife Biology in Practice. 2014; 10(1):14-23. doi:10.2461/wbp.2014.10.3
24. Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF. Metabolomic studies of human lung carcinoma cell lines using in vitro (1)H NMR of whole cells and cellular extracts. NMR in biomedicine. 2008; 21(8):809-19. doi:10.1002/nbm.1258 PMID: 18470962
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Canadian journal of biochemistry and physiology. 1959; 37(8):911-7. PMID: 13671378.
26. Wu H, Southam AD, Hines A, Viant MR. High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Analytical biochemistry. 2008; 372(2):204-12. doi:10.1016/j.ab.2007.10.002 PMID: 17963684.
27. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995; 57(1):289-300.
28. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the Human Metabolome Database. Nucleic acids research. 2007; 35(Database issue):D521-6. doi:10.1093/nar/gkl923 PMID: 17202168; PubMed Central PMCID: PMC1899095.
29. Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, et al. Metabolite identification via the Madison Metabolomics Consortium Database. Nature biotechnology. 2008; 26(2):162-4. doi:10.1038/nbt0208-162 PMID: 18259166.
30. Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, et al. BioMagResBank. Nucleic acids research. 2008; 36(Database issue):D402-8. PMID: 17984079.
31. Smith JE, Chavey PS, Miller RE. Iron Metabolism in Captive Black (Diceros bicornis) and White (Ceratotherium simum) Rhinoceroses. Journal of Zoo and Wildlife Medicine. 1995; 26(4):525-31.
32. Yamato M, Muto Y, Yoshida T, Kato M, Moriwaki H. Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. International Hepatology Communications. 1995; 3(2):91-6. http://dx.doi.org/10.1016/0928-4346(94)00159-3.
33. Kuwahata M, Yoshimura T, Sawai Y, Amano S, Tomoe Y, Segawa H, et al. Localization of polypyrimidine-tract-binding protein is involved in the regulation of albumin synthesis by branched-chain amino acids in HepG2 cells. The Journal of nutritional biochemistry. 2008; 19(7):438-47. Epub 2007/08/21. doi:10.1016/j.jnutbio.2007.05.011 PMID: 17707630.
34. Nishitani S, Ijichi C, Takehana K, Fujitani S, Sonaka I. Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction. Biochem Biophys Res Commun. 2004; 313(2):387-9. Epub 2003/12/20. PMID: 14684173.
35. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007; 6(3):181-94. Epub 2007/09/05. doi:10.1016/j.cmet.2007.08.003 PMID: 17767905; PubMed Central PMCID: PMCPmc2693888.
36. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun. 2002; 299(5):693-6. Epub 2002/12/10. PMID: 12470633.
37. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatology research: the official journal of the Japan Society of Hepatology. 2006; 35(3):204-14. Epub 2006/06/02. doi:10.1016/j.hepres.2006.04.007 PMID: 16737844.
38. Korenaga M, Nishina S, Korenaga K, Tomiyama Y, Yoshioka N, Hara Y, et al. Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice. Liver international: official journal of the International Association for the Study of the Liver. 2015; 35(4):1303-14. Epub 2014/08/27. doi:10.1111/liv.12675 PMID: 25156780; PubMed Central PMCID: PMCPmc4409847.
39. James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet (London, England). 1979; 2(8146):772-5. Epub 1979/10/13. PMID: 90864.
40. Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW. Aromatic amino acid metabolism during liver failure. The Journal of nutrition. 2007; 137(6 Suppl 1):1579S-85S; discussion 97S-98S. Epub 2007/05/22. PMID: 17513430.
41. Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, et al. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg. 1974; 127(1):40-7. Epub 1974/01/01. PMID: 4808685.
42. Soeters PB, Fischer JE. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet (London, England). 1976; 2(7991):880-2. Epub 1976/10/23. PMID: 62115.
43. Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. World Journal of Gastroenterology: WJG. 2013; 19(43):7620-9. doi:10.3748/wjg.v19.i43.7620 PMID: PMC3837260.
44. Beben T, Rifkin DE. GFR Estimating Equations and Liver Disease. Advances in chronic kidney disease. 2015; 22(5):337-42. Epub 2015/08/28. doi:10.1053/j.ackd.2015.05.003 PMID: 26311594; PubMed Central PMCID: PMCPmc4552961.
45. Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Archives of internal medicine. 1994; 154(2):201-5. Epub 1994/01/24. PMID: 8285815.
46. MacAulay J, Thompson K, Kiberd BA, Barnes DC, Peltekian KM. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: Are the equations for estimating renal function better? Canadian Journal of Gastroenterology. 2006; 20(8):521-6. PMID: PMC2659934.
47. Serra MA, Puchades MJ, Rodriguez F, Escudero A, del Olmo JA, Wassel AH, et al. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis. Scandinavian journal of gastroenterology. 2004; 39(11):1149-53. Epub 2004/11/17. doi:10.1080/00365520410008024 PMID: 15545175.
48. Parsons HM, Ekman DR, Collette TW, Viant MR. Spectral relative standard deviation: a practical benchmark in metabolomics. The Analyst. 2009; 134:478-85. doi:10.1039/b808986h Epub 2008 Dec 2. PMID: 19238283.